SEC Form 4 reporting owner

Lloyd George W.

Lloyd George W. has filed 2 Form 4 transactions reported between December 17, 2025 and December 18, 2025, as EVP, Investments & CLO of Royalty Pharma plc.

Name as filed: Lloyd George W.

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$4.2M
2 lines
Companies
1
with Form 4 filings
Latest transaction
Dec 18, 2025
transaction date

Roles and reported holdings

  • RPRXRoyalty Pharma plc
    Dec 17, 2025 – Dec 18, 2025

    EVP, Investments & CLO

    Held indirectly (latest line)0 sh as of Dec 18, 2025 · Form 4

    24 months: $4.2M sold

Transaction history

All 2 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Dec 18, 2025RPRXEVP, Investments & CLOOpen-market saleCode S · indirect30,654$1.2M@ $38.50Form 4
Dec 17, 2025RPRXEVP, Investments & CLOOpen-market saleCode S · indirect79,346$3.1M@ $38.57Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.